Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
D000813:Anilides / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000517:prevention & control; D044482:Benzeneacetamides; D003327:Coronary Disease / Q000150:complications; D016700:Encainide; D005424:Flecainide; D006352:Heart Ventricles; D006801:Humans; D008012:Lidocaine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000150:complications; D010880:Piperidines / Q000627:therapeutic use; D013610:Tachycardia / Q000517:prevention & control; D016677:Tocainide; D014693:Ventricular Fibrillation / Q000517:prevention & control
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D044482:Benzeneacetamides; D010880:Piperidines; D008801:Mexiletine; D016677:Tocainide; D008012:Lidocaine; D005424:Flecainide; C015970:lorcainide; D016700:Encainide